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Abstract
Knowledge concerning mechanisms that control proliferation and differentiation of preadipocytes 
is essential to our understanding of adipocyte hyperplasia and the development of obesity. 
Evidence has shown that temporal regulation of mitogen-activated protein kinase (MAPK) 
phosphorylation and dephosphorylation is critical for coupling extracellular stimuli to cellular 
growth and differentiation. Using differentiating 3T3-L1 preadipocytes as a model of adipocyte 
hyperplasia, we examined a role for dual-specificity phosphatase 1 (DUSP1) on the timely 
modulation of MAPK signaling during states of growth arrest, proliferation, and differentiation. 
Using real-time reverse transcription PCR (qRT-PCR), we report that DUSP1 is induced during 
early preadipocyte proliferation concomitant with ERK and p38 dephosphorylation. As 
deactivation of ERK and p38 is essential for the progression of adipocyte differentiation, we 
further showed that de novo mRNA synthesis was required for ERK and p38 dephosphorylation, 
suggesting a role for “inducible” phosphatases in regulating MAPK signaling. Pharmacological 
and genetic inhibition of DUSP1 markedly increased ERK and p38 phosphorylation during early 
adipocyte differentiation. Based on these findings, we postulated that loss of DUSP1 would block 
adipocyte hyperplasia. However, genetic loss of DUSP1 was not sufficient to prevent preadipocyte 
proliferation or differentiation, suggesting a role for other phosphatases in the regulation of 
adipogenesis. In support of this, qRT-PCR identified several MAPK-specific DUSPs induced 
during early (DUSP2, −4, −5,&−6), mid (DUSP4&−16) and late (DUSP9) stages of adipocyte 
differentiation. Collectively, these data suggest an important role for DUSPs in regulating MAPK 
dephosphorylation, with an emphasis on DUSP1, during early adipogenesis.
Obesity is a major risk factor for the development of stroke, heart disease, and type 2 
diabetes (Haslam and James, 2005). Obesity develops from an increase in adipose tissue 
(AT) mass due to enlargement of adipocyte size (hypertrophy) and cell number (hyperplasia) 
(Hirsch and Batchelor, 1976; Knittle et al., 1979). Mature adipocytes are post-mitotic; 
therefore hyperplasia refers to the recruitment of new adipocytes through proliferation and 
subsequent differentiation of adipocyte precursor cells referred to as “preadipocytes.” 
*Correspondence to: Ron F. Morrison, Department of Nutrition, The University of North Carolina at Greensboro, 318 Stone Building, 
Greensboro, NC 27402, rfmorris@uncg.edu. 
Conflicts of interest: The authors declare that there are no conflicts of interest.
HHS Public Access
Author manuscript
J Cell Physiol. Author manuscript; available in PMC 2020 October 21.
Published in final edited form as:













Preadipocyte replication slows during adulthood, yet adipocyte hyperplasia has been shown 
to play a critical role in the onset of obesity throughout all stages of life, particularly during 
childhood obesity and in morbidly obese adults (Faust et al., 1978; Bjorntorp et al., 1982; 
Hirsch et al., 1989; Hausman et al., 2001). Unlike hypertrophic obesity, exercise, and caloric 
restriction are less effective in treating obesity derived from adipocyte hyperplasia (Faust et 
al., 1978; Yang et al., 1980; Mandenoff et al., 1982). Despite evidence suggesting that 
hyperplastic obesity is associated with the poorest prognosis of treatment, mechanisms 
regulating adipocyte hyperplasia remain poorly understood.
Intracellular signaling molecules play a critical role in linking environmental cues to 
increased adipocyte hyperplasia. Of the major signal transduction cascades, mitogen-
activated protein kinases (MAPKs) have been shown to be essential for both adipocyte 
proliferation and differentiation (Bost et al., 2005a,b; Aouadi et al., 2007). In the adipocyte, 
extracellular signal-regulated kinase (ERK) and p38 are the best characterized MAPKs 
known to play a pivotal role in adipogenesis (Bost et al., 2005a). Timely phosphorylation as 
well as dephosphorylation of ERK and p38 is critical for adipocyte hyperplasia as loss of 
ERK phosphorylation as well as prolonged ERK phosphorylation has been shown to inhibit 
adipogenesis (Engelman et al., 1998, 1999; Prusty et al., 2002; Bost et al., 2005a,b; Aouadi 
et al., 2007). In addition to temporal regulation, MAPK nuclear localization has been shown 
to regulate adipocyte hyperplasia through transcriptional mechanisms involving adipocyte 
gene expression (Prusty et al., 2002; Park et al., 2004), demonstrating that 
compartmentalized signaling events can impact different properties of adipocyte 
differentiation.
It is well established that MAPK activity is regulated by a cascade of phosphorylation events 
mediated by sequential activation of upstream kinases, where MAPK is phosphorylated by 
upstream MAPK kinases (MAP2Ks), which are phosphorylated by MAPK kinase kinases 
(MAP3Ks) in response to diverse external stimuli. Phosphorylation of both threonine and 
tyrosine residues of the (T-X-Y) motif within the activation loop is essential and sufficient 
for MAPK activity (Pearson et al., 2001; Tanoue and Nishida, 2003; Zhang and Dong, 
2007). While MAPK activity has traditionally been attributed to upstream kinases, recent 
evidence suggests that MAPK dephosphorylation via phosphatases plays a central role in 
controlling MAPK-dependent biological processes (Ebisuya et al., 2005; Dickinson and 
Keyse, 2006; Kondoh and Nishida, 2007). Dual-specificity phosphatases (DUSPs) are a 
subclass of protein tyrosine phosphatases that specifically inhibit MAPK activity through 
dephosphorylation of both threonine and tyrosine residues. Within this subclass, there are 
ten DUSPs that contain a MAP Kinase Binding (MKB) domain that selectively confers 
catalytic activity toward ERK, c-Jun N-terminal kinases (JNK) or p38 (Dickinson and 
Keyse, 2006; Kondoh and Nishida, 2007; Zhang and Dong, 2007). These MAPK-specific 
DUSPs are further classified based on gene structure, substrate specificity, and subcellular 
localization into three groups composed of nuclear DUSPs, cytosolic ERK-specific DUSPs, 
and DUSPs that selectively inactivate JNK and p38 MAPKs (Table 1). Lastly, DUSPs are 
highly inducible at the level of gene expression in a cell-type and stimulus-dependent 
manner (Dickinson and Keyse, 2006; Jeffrey et al., 2007; Keyse, 2008). For adipocytes, 
these stimuli include insulin and the synthetic glucocorticoid dexamethasone (Kusari et al., 
1997; Kassel et al., 2001).
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Increasing attention has been given to MAPK-specific DUSPs regarding adipocyte 
differentiation and insulin resistance (IR) (Xu et al., 2003b; Bazuine et al., 2004; Sakaue et 
al., 2004; Wu et al., 2006; Emanuelli et al., 2008; Feng et al., 2014). Of the ten DUSPs 
examined, the archetypal member, DUSP1 has emerged as a key player in diet-induced 
obesity and IR (Wu et al., 2006). Considering the role for DUSPs on MAPK signaling, we 
explored the functional role for DUSP1 on MAPK activity and adipocyte differentiation. 
Initial characterization of DUSP1 demonstrated increased expression of the phosphatase in 
animal models of genetic and diet-induced obesity in the presence of increasing 
inflammation. Using the murine 3T3-L1 cell line as a model for adipocyte hyperplasia, we 
further show that dephosphorylation of ERK and p38 during early preadipocyte proliferation 
was strongly correlated to DUSP1 expression. Consistent with this observation, 
pharmacological and genetic inhibition of DUSP1 resulted in sustained phosphorylation of 
ERK and p38. Paradoxically, the sustained MAPK phosphorylation observed with DUSP1 
knockdown was not sufficient to block adipogenesis. Based on these findings, we further 
showed that additional DUSPs were induced during early (DUSP2, −4, −5, & −6), mid 
(DUSP4 & −16) and late (DUSP9) stages of adipocyte differentiation. Collectively, these 
data support a role for DUSPs, in particular DUSP1, as negative regulators of MAPK 
activity and highlight redundancies among these phosphatases in the regulation of MAPK 
signaling and adipogenesis.
Materials and Methods
Mice and experimental diets
Animals used for this study include genetically obese male B6.VLepob/J (B6-ob/ob) mice 
and their lean littermates as well as C57BL/6J mice rendered obese by diet and their lean 
controls. All mice were housed and treated by the supplier (Jackson Laboratories, Bar 
Harbor, Maine) until shipment 1 week prior to tissue harvest. B6-ob/ob mice and lean 
littermates were purchased for experimentation at 6 and 10 weeks of age and given free 
access to a standard laboratory chow diet. According to Jackson Labs, mice homozygous for 
the obese mutation exhibit hyperplasia with ensuing obesity notable at 1 month of age and 
transient glucose intolerance that begins at ~6 weeks of age and subsides between 12 to 16 
weeks of age. C57BL/6J mice subjected to diet-induced obesity (DIO) were fed a high fat 
diet (HFD) consisting of 60% kcal from fat (Research Diets Inc. D12492) from 6 weeks of 
age. Lean C57BL/6J control mice were fed a control low fat diet (LFD) consisting of 10% 
kcal from fat (Research Diet Inc. D12450B) from 6 weeks of age. Both diets contained 10% 
kcal from protein with the balance in caloric value provided by differences in carbohydrate 
content. Mice receiving both diets were given free access to food and shipped for 
experimentation at 18 and 24 weeks of age. All animals were euthanized by CO2 gas 
asphyxiation and epididymal white AT (WAT) tissue collected and processed for preparation 
of total RNA. Animal care and use was in compliance with the Institute of Laboratory 
Animal Research Guide for the Care and Use of Laboratory Animals and approved by the 
Institutional Animal Use and Care Committee.
Materials.—Dulbecco’s Modified Eagle’s Medium (DMEM), calf bovine serum (CS), and 
trypsin-EDTA were purchased from Invitrogen. Fetal bovine serum (FBS) was obtained 
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from HyClone. Antibodies used for immunoblotting include phospho-ERK, phosho-p38, 
total p38, aP2, GAPDH, and α-tubulin purchased from Cell Signaling and DUSP1, PPARγ, 
C/EBPβ and C/EBPα purchased from Santa Cruz Biotechnology. Enhanced 
chemiluminescence (ECL) reagents were obtained from Perkin-Elmer Life Sciences. 
Actinomycin D was purchased from Sigma Aldrich. Triptolide was obtained from 
Calbiochem. All Taqman primer probes (Table 1) used in this study were purchased from 
Applied Biosystems. The murine 3T3-L1 cell line was purchased from Howard Green, 
Harvard Medical School (Djian et al., 1985).
Cell culture.—3T3-L1 preadipocytes were propagated in DMEM supplemented with 10% 
CS until density-induced growth arrest, as previously described (Morrison and Farmer, 
1999b). At 2 days post-confluence, growth medium was replaced with DMEM 
supplemented with 10% FBS, 0.5 mM 1-methyl-3-isobutylxanthine, 1 μM dexamethasone, 
and 1.7 μM insulin (MDI). Throughout the study, “time 0” refers to density arrested cells 
immediately before the addition of MDI to the culture medium. Experiments described 
herein were conducted within the period of differentiation spanning from density arrest (d0) 
through 8 days (d8) post-MDI. All experiments were repeated 2–3 times to validate results 
and ensure reliability.
Immunoblotting.—Cell monolayers were washed with phosphate-buffered saline (PBS) 
and scraped into ice-cold lysis buffer containing 1.0 M Tris, pH 7.4, 150 mM NaCl, 1% 
Triton X, 0.5% Nonidet P-40 (NP40), 1 mM EDTA, 1 mM EGTA, and 10 mM N-
ethylmaleimide. Phosphatase (20 mM ß-glycerophosphate, 10 mM NaFl, and 2 μM sodium 
vanadate), as well as protease (0.3 μM aprotonin, 21 μM leupeptin, 1 μM pepstatin, 50 μM 
phenanthroline, and 0.5 μM phenylmethylsulfonyl fluoride) inhibitors were added to lysis 
buffer prior to cell harvest. Cell lysates were sonicated, centrifuged (13,000g, 10 min, 4°C), 
and the supernatant transferred to a fresh tube. Bicinchoninic acid assay (Pierce, Rockford, 
IL) was used to determine protein concentration. Cell lysates were resuspended in loading 
buffer containing 0.25 M Tris, pH 6.8, 4% sodium dodecyl sulfate (SDS), 10% glycerol, 
10% dithiothreitol, and 0.01% bromophenol blue and heated for 5 min at 80°C. Proteins 
were resolved on SDS-polyacrylamide gel electrophoresis gels (PAGE) and transferred to 
polyvinylidene fluoride membranes (Millipore Corp., Billerica, MA). After transfer, 
membranes were blocked with 4% milk and probed with indicated primary antibodies 
overnight at 4°C. Membranes were subsequently probed with horseradish peroxidase-
conjugated secondary antibodies for 1 h at room temperature. Immunoblots were immersed 
in ECL and visualized by autoradiography using CL-XPosure film (Pierce).
Real-time qRT-PCR.—Total RNA was extracted and genomic DNA contamination was 
removed using the RNeasy Plus Mini Kit (Qiagen) following the manufacturer’s protocol. 
Total RNA was quantified with a Nanodrop ND-1000 spectrophotometer and reverse-
transcribed to cDNA in a 10 ml reaction volume using a high capacity cDNA reverse 
transcription kit (Applied Biosystems). The reverse transcription (RT) master mix containing 
RT buffer, deoxyribonucleotide triphosphate (dNTP) mix, RT random primers, RNase 
inhibitor (1.0 U/μl), and MultiScribe RT was added to 1 μg RNA and RNase-free water. 
Reverse transcription reaction conditions followed the protocol (25°C for 10 min, 37°C for 
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120 min, 85°C for 5 sec, followed by 4°C indefinitely/RT complete) and utilized the Gene 
Amp PCR System 9700 thermal cycler (Applied Biosystems) for cDNA synthesis.
PCR amplification was run utilizing the 7500 fast system (Applied Biosystems) that 
consisted of enzyme activation at 95°C for 20 sec, followed by 40 cycles of denaturation at 
95°C for 3 sec combined with annealing/extension at 60°C for 30 sec All data were analyzed 
with the ABI 7500 real time PCR system (Applied Biosystems). Data were recorded and 
analyzed with Sequence Detector Software (Applied Biosystems) and graphs visualized with 
SigmaPlot software. All data were presented as mean ± standard error of the mean (SEM) 
and representative of at least two experiments performed in duplicate. Data were normalized 
to 18S previously validated by this lab as a suitable reference gene under these experimental 
conditions (Ferguson et al., 2010). Relative differences between treated and untreated 
control samples were analyzed by the 2−ΔΔCT method as previously described (Livak and 
Schmittgen, 2001; Ferguson et al., 2010).
Statistical analyses were conducted using SPSS v18. Phenotypic differences were 
determined via student’s t-test where a P-value of <0.05 was considered significant. 
Knockdown and Inhibitor data were analyzed using analysis of variance, with Tukey’s post-
hoc analysis used when the p value for the respective parameter was statistically significant 
(P < 0.05). MDI component data were analyzed using analysis of variance, with Dunnet’s 
post-hoc analysis used when the P value for the respective parameter was statistically 
significant (P < 0.05).
Flow cytometry.—Cell monolayers were washed with PBS and trypsinized. Detached 
cells were diluted in ice-cold PBS, and gently pelleted by centrifugation (300g, 5 min, 4°C). 
PBS was decanted, and cells were fixed and permeabilized by drop-wise addition of 70% 
ethanol at −20°C while vortexing. Cells were washed in PBS and incubated in the dark for 
30 min with a propidium iodide staining solution (50 μg/ml propidium iodide and 100 μg/ml 
RNase A in PBS). DNA fluorescence was measured with using the Guava easyCyte HT flow 
cytometer (Millipore) equipped with a 488-nm argon laser. Width (FL2W) and area (FL2A) 
of propidium iodide fluorescence were recorded for at least 5,000 counts, and DNA 
histograms were extracted from FL2W-FL2A dot plots. Histograms were analyzed with 
Modfit software.
RNA interference
SMARTpools containing four different short interfering RNAs (siRNAs) for dusp1 specific 
sequences as well as non-targeting sequences were transfected using DharmaFect 3 
transfection reagent according to manufacturer’s (Dharmacon) protocol. Briefly, 3T3-L1 
preadipocytes were propagated in 6-well culture dishes until reaching density-induced 
growth arrest. Growth medium was then replaced with DMEM supplemented with 10% CS, 
3 μl DharmaFect 3 reagent and either 100 nM DUSP1 specific siRNA or non-targeting 
siRNA for 72 h Growth medium was subsequently switched to differentiation medium 
containing MDI as described above.
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Regulation of DUSP1 in adipose tissue of genetic and diet-induced obesity
Others have reported that DUSP1 null mice were resistant to diet-induced obesity (Wu et al., 
2006). In addition, it has recently been reported that DUSP1 is elevated in adipose tissue of 
obese, non-diabetic patients, concomitant to p38 dephosphorylation (Khadir et al., 2015). 
Thus, we initially sought to examine the developmental role of obesity on DUSP1 gene 
expression. For genetic obesity development, B6-ob/ob mice and wildtype littermates were 
purchased (Jackson Laboratory) for studies conducted at 6 and 10 weeks of age. The age of 
mice chosen for this study represented developmental stages of obesity which were 
arbitrarily designated as stage I (6 weeks) and stage II (10 weeks) for comparison (see 
Materials and Methods). Consistent with progressive development of obesity, 6 and 10 
weeks old B6-ob/ob mice presented with 67% and 83% increases in body weight, 
respectively, relative to lean (control) littermates (Table 2). For development of diet-induced 
obesity (DIO), C57BL/6J males were given ad libitum access to a high fat diet (HFD; 60% 
kcal) starting at six weeks of age. Control males were fed a control low fat diet (LFD) 
containing 10% kcal from fat and the same protein content and total caloric value as the 
HFD. Studies were conducted at 18 weeks (stage I) and 24 weeks (stage II) of age, 
representing 12 weeks and 18 weeks of specialized diet, respectively. As shown in Table 2, 
18 and 24 week old mice fed a HFD in this study presented with 13% and 26% increases in 
body weight, respectively, relative to lean mice fed the LFD.
RNA was isolated from white adipose tissue (WAT) of epididymal fat pads in male B6-ob/ob 
and DIO mice and assessed by qRT-PCR, normalized to 18S rRNA, and presented relative to 
lean controls. Obesity is characterized by a progressive increase in chronic, low-grade 
inflammation (Xu et al., 2003a; Strissel et al., 2007; Gregor and Hotamisligil, 2011). 
Therefore, we first assessed the relative mRNA abundance of two major cytokines, IL-6 and 
TNFα. Both cytokines were elevated only in stage II of B6-ob/ob mice fed standard chow 
consistent with the premise of progressive obesity-induced inflammation (Fig. 1A and B). 
IL-6 and TNFα were elevated in DIO mice at both stages of obesity, but with a progressive 
increase in TNFα correlating with subsequent stages of obesity (Fig. 1C and D). Finally, 
relative DUSP1 gene expression was examined in adipose tissue during the development of 
obesity and inflammation as assessed above. DUSP1 was elevated in obese adipose tissue 
only during conditions that also displayed an increase in TNFα (Fig. 1A–D).
Early induction of DUSP1 tightly correlates with MAPK dephosphorylation during early 
adipocyte differentiation
It is well established that ERK and p38 play functional roles during adipocyte 
differentiation; however the extent (i.e., magnitude and duration) of MAPK activity during 
distinct stages of differentiation remains uncertain (Bost et al., 2005a,b; Aouadi et al., 2007). 
It has been reported that MAPK activity is required for early stages of differentiation but 
inhibits late stages of differentiation, suggesting that “timing” of activity is critical for 
proper adipocyte differentiation. To elucidate a role for phosphorylation and 
dephosphorylation mechanisms regarding MAPK activity during adipocyte hyperplasia, we 
utilized the well-established 3T3-L1 murine cell line for this study. This cell line 
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synchronously progresses through distinct stages of the cell cycle before entering a state of 
terminal growth arrest. Concomitant with growth arrest is the upregulation of a cascade of 
transcription factors that mediate late stage adipocyte gene expression and acquisition of the 
functional adipocyte phenotype.
To determine the extent of MAPK activity during these distinct stages of adipocyte 
differentiation, density-arrested preadipocytes were stimulated with a hormonal cocktail 
(i.e., MDI) and cell lysates harvested over early (0–24 hr) and late (d0–d8) stages of 
differentiation and immunoblotted with phosphospecific antibodies that recognize MAPKs 
only when bisphosphorylated on the T-x-Y motif of the activation loop. As shown in Figure 
2, ERK and p38 were rapidly phosphorylated (15 min) and then completely 
dephosphorylated (<4 hr) during early adipocyte differentiation (panel A). Also shown is the 
phosphorylation state of MEK, the upstream MAP2K responsible for ERK phosphorylation, 
demonstrating that ERK was completely dephosphorylated 6–10 hrs before MEK 
phosphorylation returned to baseline (Fig. 2A). It should be noted that ERK 
dephosphorylation occurred with induction of PPARγ gene expression, which is a known 
target of ERK whose transcriptional activity is suppressed when phosphorylated by ERK 
(Hu et al., 1996). Lastly, while p38 phosphorylation was nearly identical to ERK during the 
first 4 hrs of differentiation (Fig. 2A), the phosphorylation state of p38 displayed a biphasic 
pattern that was not similar to ERK during later stages of differentiation (Fig. 2C). 
Immunoblot analysis of total p38 remained unchanged during all stages of adipocyte 
differentiation and served as a loading control (Fig. 2A–C). These data suggest a role for 
phosphatases in the regulation of MAPK dephosphorylation. Consistent with this 
hypothesis, we further showed that DUSP1 mRNA (Fig. 2B) and protein (Fig. 2A) 
expression increased during early adipocyte differentiation in a manner consistent with 
MAPK dephosphorylation. However, DUSP1 expression was markedly reduced during late 
stages of adipocyte differentiation (note difference in scale of Y-axis between panels B and 
D), highlighting a potential role for this phosphatase during early, but not late stages of 
adipogenesis (Fig. 2C and D).
Pharmacological inhibition of DUSP1 amplified MAPK phosphorylation during early 
adipocyte differentiation
Data presented above demonstrated that DUSP1 expression strongly correlates with the 
deactivation of MAPK signaling. As others have shown that DUSP1 acts as an immediate 
early gene to regulate MAPK signaling (Dickinson and Keyse, 2006), we initially examined 
if ERK and p38 signaling was involved in de novo mRNA synthesis. For this, preadipocytes 
were pretreated with and without 1 ng/ml actinomycin D (Actino D) for 30 mins to inhibit 
mRNA synthesis prior to stimulation with MDI. Cell lysates were harvested over time 
during early adipocyte differentiation (<24 h) and immunoblotted for phosphorylated ERK 
and p38 as well as DUSP1 as discussed above. Blocking RNA synthesis resulted in a marked 
decrease in DUSP1 protein expression concomitant with an increase in ERK 
phosphorylation extending from less than 4 h in the absence of Actino D to more than 24 h 
when RNA synthesis was inhibited (Fig. 3A). Inhibition of RNA synthesis also had a 
marked effect of increased p38 phosphorylation (Fig. 3A). While MAPK dephosphorylation 
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was dependent on de novo mRNA synthesis, initial MAPK phosphorylation (0 hr) was 
unaffected by Actino D (Fig. 3A).
To further determine a role for DUSP1 on the extent of MAPK phosphorylation during early 
adipocyte differentiation, preadipocytes were pretreated with or without 1 μM triptolide 
(TRP) for 30 min prior to MDI stimulation. TRP is a bioactive compound purified from the 
Chinese herb Tripterygium wilfordii and shown to be effective as an immunosuppressant 
and anti-inflammatory agent as well as a potent inhibitor of DUSP1 gene expression (Liu, 
2011). To determine if TRP influenced MAPK phosphorylation, cell lysates were harvested 
over time and immunoblotted for phosphorylated ERK and p38 as well as DUSP1. MDI 
stimulation markedly increased ERK and p38 phosphorylation. In the absence of TRP, MDI 
stimulation also resulted in the accumulation of DUSP1 protein in a manner consistent with 
the dephosphorylation of both MAPKs (Fig. 3B). In contrast, TRP pretreatment abolished 
the accumulation of DUSP1 and prolonged phosphorylated ERK and p38 through 24 hrs 
post-MDI stimulation. Pretreatment with TRP did not block the phosphorylation of either 
MAPK by upstream MAPK kinases following MDI stimulation. Together, these data support 
a role for DUSP1 in modulating the extent of MAPK phosphorylation during early adipocyte 
differentiation.
DUSP1 knockdown enhanced MAPK signaling during 3T3-L1 preadipocyte differentiation
To further establish a mechanistic role for DUSP1 on MAPK signaling, 3T3-L1 PAs were 
transfected with siRNA targeted to DUSP1 or non-targeting control sequences for 72 h prior 
to stimulation with MDI. Total RNA and whole cell lysates were harvested over time and 
analyzed for DUSP1 mRNA abundance and MAPK phosphorylation. DUSP1 gene 
expression was markedly induced during early differentiation in cells transfected with 
control siRNA (Fig. 4A). In contrast, both basal (>70%) and MDI-stimulated (>60%) 
expression of DUSP1 mRNA was significantly suppressed in cells treated with DUSP1 
specific siRNA. Specific knockdown of DUSP1 mRNA nearly ablated accumulation of 
DUSP1 protein resulting from MDI stimulation (Fig. 4B). Moreover, specific knockdown of 
DUSP1 markedly increased ERK as well as p38 phosphorylation following MDI 
stimulation. Total p38 and α-Tubulin served as loading controls and remained unchanged 
(Fig. 4B).
PKA and ERK signaling regulate DUSP1 expression
Data presented above demonstrated a role for DUSP1 as an immediate early gene that 
regulates MAPK dephosphorylation during early adipogenesis. However, how DUSP1 is 
regulated under conditions of adipocyte differentiation remain unknown. Reports suggest a 
canonical feedback loop whereby MAPK-mediated induction of DUSP gene expression 
results in the expression of targeted phosphatases that specifically inhibit MAPK activity. To 
initially address this question, 3T3-L1 preadipocytes were treated with components of the 
adipogenic cocktail, 1-methyl-3-isobutylxanthine, dexamethasone, and insulin (MDI), 
individually or in combination and DUSP1 mRNA expression was analyzed at 1 h post-
stimulation via qRT-PCR. As shown in Figure 5A, methyl-isobutylxanthine (Mix), a known 
activator of cAMP/PKA signaling, was the prominent regulator of DUSP1 mRNA 
expression. DUSP1 mRNA expression was also significantly elevated by treatment with 
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dexamethasone (Fig. 5A). However, it should be noted that DUSP1 message was 
significantly upregulated in all conditions in which Mix was present (Fig. 5A). Intriguingly, 
induction of DUSP1 mRNA expression mirrored that of C/EBPβ, a key transcriptional 
regulator of early adipogenesis (Fig. 5B) (Morrison and Farmer, 1999a). Consistent with a 
role for cAMP signaling, MDI-mediated induction of DUSP1 mRNA expression was 
significantly attenuated in the presence of the cAMP/PKA inhibitor H-89 (Fig. 5C). DUSP1 
mRNA expression was also reduced in the presence of the specific MEK inhibitor, UO126, 
albeit to a significantly lesser extent, suggesting cross-talk between cAMP/PKA and ERK 
pathways (Fig. 5C). Consistent with the MDI experiment above, complete loss of DUSP1 
and C/EBPβ protein expression occurred in the presence of PKA inhibition (Fig. 5D).
DUSP1 knockdown does not inhibit adipocyte hyperplasia
Data presented above demonstrated that DUSP1 regulates MAPK dephosphorylation during 
early adipocyte differentiation. As recent reports differ on the role of DUSP1 during 
adipogenesis (Sakaue et al., 2004; Wu et al., 2006), we sought to examine the biological role 
of DUSP1 on preadipocyte proliferation and differentiation as essential components of 
adipocyte hyperplasia. A continuum of sequential events culminates in the activation of 
PPARγ and C/EBPα in order to regulate adipocyte gene expression and acquisition of the 
mature adipocyte phenotype during adipogenesis (Morrison and Farmer, 1999a; Rosen and 
Spiegelman, 2000). Among the early events leading to PPARγ and C/EBPα, is an 
‘obligatory’ prerequisite period of mitotic clonal expansion, in which density-arrested 
preadipocytes synchronously re-enter the cell cycle prior to activation of adipocyte-specific 
genes and terminal growth arrest (Tang et al., 2003). To determine if DUSP1 plays a 
regulatory role during clonal expansion, density-arrested preadipocytes were transfected 
with DUSP1 specific or non-targeting siRNA for 72 hrs prior to stimulation with MDI. Cells 
were harvested at 0 and 20 h post-MDI, fixed, and stained with propidium iodide for flow 
cytometric analysis of cell cycle progression. Two DNA peaks in the 2n and 4n range, 
representing G0/G1 and G2/M cell populations, were present in all histograms (Fig. 6A). 
Stimulation with MDI resulted in similar shifts from G0/G1 to S and G2/M phase 
populations demonstrating synchronous cell cycle progression in cells transfected with 
DUSP1 or control siRNA. To confirm these results, cell lysates were harvested under 
identical conditions and analyzed for cyclin A protein expression, which we have previously 
shown to accumulate during S phase in this cell model (Auld et al., 2007). Cyclin A protein 
accumulated with both DUSP1-specific and control siRNA, with modestly elevated cyclin A 
protein accumulation with DUSP1 knockdown (Fig. 6B). Collectively, these data 
demonstrate that DUSP1 does not block cell cycle progression, which is a known 
prerequisite for adipocyte differentiation. To the contrary, the modest increase in cyclin A 
following DUSP1 knockdown would be indicative of more efficient S-phase entry, possibly 
resulting from elevated MAPK phosphorylation.
To elucidate a role for DUSP1 on adipocyte differentiation, density-arrested preadipocytes 
were transfected with control siRNA or DUSP1 siRNA 72 hrs prior to stimulation with 
MDI. Phase contrast microscopy was used to assess changes in cell morphology and lipid 
accumulation between undifferentiated preadipocytes (d0) and fully mature adipocytes (d8). 
Preadipocytes (d0) transfected with siRNA for DUSP1 or non-targeting sequences displayed 
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nearly identical fibroblast-like morphology. Similarly, transfection with DUSP1-specific or 
non-targeting sequences prior to differentiation resulted in no discernable differences in the 
lipid-filled morphology of fully mature adipocytes (d8) (Fig. 6C). Consistent with the above 
findings, PPARγ, C/EBPα, and aP2 increased similarly with differentiation in cells 
transfected with DUSP1-specific or non-targeting control siRNA (Fig. 6D). PPARγ and C/
EBPα represent major transcription factors that mediate the expression of functional 
proteins such as the fatty acid binding protein aP2 during adipogenesis. As DUSP1 protein 
accumulation was markedly attenuated at 2 h post-MDI with DUSP1 siRNA, these data 
demonstrate that knockdown of DUSP1 alone was not sufficient to block adipogenesis.
Inducible DUSP gene expression during adipocyte differentiation
Data presented above suggest the possibility of redundant or collective roles between 
multiple phosphatases in limiting the extent of MAPK phosphorylation that is essential for 
adipocyte differentiation. Therefore, we examined relative mRNA expression of all known 
MAPK-specific DUSPs during adipocyte differentiation using qRT-PCR. All ten DUSPs 
were measurable in preadipocytes within the detectable limits of 36 threshold cycles (CT), 
with dusp2, dusp8, and dusp9 least abundantly expressed at 32 cycles and dusp1, dusp6, and 
dusp7 most abundantly expressed at 24 cycles. This 8 cycle difference was equivalent to a 
256-fold difference (i.e., 28) in base-line mRNA abundance in preadipocytes (Table 1). To 
determine which DUSPs were induced at the level of gene expression during differentiation, 
preadipocytes were stimulated with MDI and relative mRNA abundance assessed by qRT-
PCR over time representing early (Panel A and B) and late stage (Panel C and D) 
differentiation. Prior to these studies, we set an arbitrary threshold of twofold change as a 
conservative measure of biological differences versus technical variation as measured by 
qRT-PCR (Gorzelniak et al., 2001). Thus, DUSP gene expression was only considered 
“inducible” when relative mRNA levels exceeded this threshold.
As illustrated in Figure 7A, DUSP2, −4, −5, and −6 were rapidly and transiently induced 
following induction of differentiation with DUSP2 and −5 reaching greater than 10-fold 
changes in mRNA by 2 hrs post-MDI. DUSP2 and −5 mRNA rapidly declined with values 
remaining at or below baseline from 12 hrs through d10 of differentiation (Fig. 7A–D). 
DUSP4 was unique among these phosphatases with biphasic expression with a transient, 
smaller peak (threefold) occurring at 4 hrs and a more sustained, larger peak (sevenfold) 
occurring at 4 d and remaining above baseline through d10 (Fig. 7A–C). While the kinetic 
profile of these DUSPs was consistent with the timing of MAPK dephosphorylation during 
early stages of differentiation, the mid-stage biphasic induction of DUSP4 occurred 
concomitantly with the time period when ERK phosphorylation falls below baseline levels 
and PPARγ is expressed. DUSP6 was the only cytosolic phosphatase determined to be 
rapidly and transiently induced during early adipocyte differentiation where a 3.5-fold 
induction peaked at 1 h and returned to baseline within 12 hrs post-MDI (Fig. 7A). In 
contrast, DUSP9 displayed a reciprocal pattern of expression where mRNA fell below 
baseline during early stages of differentiation (Fig. 7B) followed by a gradual induction 
during late stages remaining markedly elevated (eightfold) through d10 of differentiation 
(Fig. 7C). Finally, DUSP16 was transiently induced during late stages with peak mRNA 
abundance observed at d4 of differentiation (Fig. 7C). Intriguingly, DUSP2, 5, 6 were also 
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induced in response to obesity as observed with DUSP1 (Fig. 8). Together, these data 
support redundant or collective roles for multiple DUSPs in the regulation of MAPK 
signaling and adipogenesis.
Discussion
This report highlights the mechanistic actions of DUSP1 as a negative regulator of ERK and 
p38 signaling during early adipocyte differentiation. Moreover, we present evidence that 
suggest a redundant and/or co-operative role for “inducible” DUSPs as negative regulators 
of MAPK activity during adipogenesis. We propose a model in which mitogenic signaling 
promotes DUSP expression in order to regulate MAPK activity throughout adipocyte 
differentiation (Fig. 9). We further showed that agonist-mediated induction of DUSP1 was 
dependent on cAMP/PKA and ERK signaling demonstrating feedback regulation of 
mitogenic signaling cascades by targeted phosphatases. These findings define a previously 
unexplored role for DUSP1 on the regulation of MAPK signaling during early adipogenesis.
Data presented here demonstrate that DUSP1 was divergently regulated at the level of gene 
expression based on the inflammatory environment resulting from obesity. Chronic-low 
grade inflammation is a cardinal hallmark of obesity, where increased inflammation (e.g., 
TNFα and IL-6) has been shown to drive adipocyte dysfunction and block adipogenesis 
(Torti et al., 1989; Stephens et al., 1992; Stephens and Pekala, 1992). We show that DUSP1 
was induced in adipose tissue under conditions of genetic or diet-induced obesity where 
inflammatory genes (i.e., IL-6 and TNFα) were elevated. Conversely, DUSP1 was not 
elevated during early stage (i.e., stage I) of B6-ob/ob obesity even though these mice 
presented with a 67% increase in body weight in obese versus lean adipose tissue, 
suggesting that inflammation-mediated induction of DUSP1 is necessary for MAPK 
dephosphorylation in order to maintain adipocyte function and adipogenesis. While our data 
are the first to demonstrate elevated DUSP1 gene expression in adipose tissue of obese mice, 
others have shown that mice fed a HFD present with increased DUSP1 accumulation in the 
liver (Reddy et al., 2004) and that whole body DUSP1 gene ablation protects against diet-
induced obesity in mice (Wu et al., 2006). Interestingly, DUSP1 has recently been identified 
as being differentially expressed in visceral adipose tissue of severely obese men with versus 
without metabolic syndrome, while others have shown that single nucleotide polymorphisms 
(SNPs) in the DUSP1 gene of obese individuals were associated with modulation of plasma 
glucose and HDL-cholesterol levels (Bouchard et al., 2007; Guenard et al., 2013). More 
recent data demonstrated that increased adipose tissue and circulating DUSP1 in obese, 
nondiabetic, patients positively correlated to increased inflammatory markers IP-10 and 
RANTES (Khadir et al., 2015). Taken together, obesity-associated inflammation and not 
obesity per se, appear responsible for elevated DUSP1 gene expression in adipose tissue. 
Moreover, this increase in DUSP1 may be critical for the regulation of metabolic function 
associated with obesity but not adipogenesis per se.
It is well established that DUSP1 acts as an immediate early gene whose expression is 
induced rapidly and transiently by various extracellular stimuli including agents used to 
differentiate 3T3-L1 preadipocytes such as insulin, glucocorticoids (e.g., dexamethasone), 
and cAMP analogs (Kusari et al., 1997; Schliess et al., 2000; Kassel et al., 2001). Notably, 
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we show significant induction of DUSP1 in all cases where Mix is present. Historical data 
has defined Mix in the regulation of PKA and ERK signaling in order to drive C/EBPβ 
expression and adipogenesis (Morrison and Farmer, 1999a, 2000). In keeping we found that 
inhibition of PKA and ERK phosphorylation blocked DUSP1 expression (Fig. 5C and D). 
Recent data however has implicated protein kinase G (PKG) signaling in the regulation of 
adipogenesis (Zhang et al., 2010). Mix is a well-known phosphodiesterase inhibitor that 
stimulates PKA and PKG signaling pathways (Huai et al., 2004). As such, we cannot 
completely rule out a role for cAMP/PKA/PKG pathways in the regulation of DUSP1 
expression. Consistent with a role for PKA and ERK signaling pathways in the regulation of 
DUSP1, we further showed that expression of C/EBPβ mirrored that of the DUSP1 gene. 
Together, these data suggest a role for the C/EBPβ transcription factor as a regulator of 
DUSP1 gene expression. Consistent with this hypothesis, reports have identified putative 
binding sites for C/EBPβ within the DUSP1 promoter and further show that binding of C/
EBPβ to these sites promotes DUSP1 mRNA expression (Cho et al., 2008; Johansson-Haque 
et al., 2008). In addition, others have shown consensus phosphorylation sites within C/EBPβ 
downstream of PKA (S299) and ERK (T188) that facilitate nuclear translocation and 
transcriptional activation of C/EBPα and adiponectin, respectively (Chinery et al., 1997; 
Park et al., 2004). Importantly, C/EBPβ is an essential transcription factor for adipocyte 
differentiation that acts to induce PPARg and C/EBPα gene expression (Wu et al., 1996; 
Park et al., 2004). Of note, loss of C/EBPβ prevents adipocyte differentiation even in the 
presence of PPARg and C/EBPα, demonstrating that adipocyte differentiation requires C/
EBPβ (Tanaka et al., 1997). Together, these data would suggest that C/EBPβ can further 
serve as a regulator of adipogenesis by upregulating the negative inhibitor of MAPK 
signaling, DUSP1, to modulate MAPK dephosphorylation.
Timely phosphorylation as well as dephosphorylation of ERK and p38 are necessary for 
adipogenesis (Engelman et al., 1998, 1999; Prusty et al., 2002; Bost et al., 2005a,b; Aouadi 
et al., 2006, 2007), where rapid and transient activation (i.e., phosphorylation) of ERK and 
p38 is essential for preadipocyte proliferation as well as the induction and activation of C/
EBPβ, both of which are required for adipocyte hyperplasia (Sale et al., 1995; Belmonte et 
al., 2001; Prusty et al., 2002; Tang et al., 2003). Conversely, prolonged ERK signaling is 
known to phosphorylate and subsequently inhibit PPARγ activity, thus blocking adipocyte 
differentiation (Hu et al., 1996). Unlike prolonged ERK activation, chronic p38 activity 
results in cell death (Engelman et al., 1998, 1999; Aouadi et al., 2007). However, the extent 
of MAPK phosphorylation during distinct stages of adipocyte differentiation remains 
unclear. Data presented here demonstrate a rapid and transient activation of ERK signaling 
during early adipocyte differentiation. Consistent with previous reports (Bost et al., 2005b), 
data presented here further demonstrate that ERK phosphorylation is suppressed during mid 
and late stages of adipocyte differentiation falling below basal expression, concomitant with 
the induction of PPARγ. As prolonged ERK phosphorylation inhibits PPARγ activity and 
subsequently adipogenesis (Hu et al., 1996), these data suggest that transient activation 
during early differentiation and suppression of ERK phosphorylation during late 
differentiation are necessary for the mature adipocyte phenotype. While phosphorylation of 
p38 during early adipocyte differentiation was similar to ERK, p38 displayed a biphasic 
pattern of signaling during late stage differentiation. While some have reported suppression 
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of p38 phosphorylation during late adipocyte differentiation (Engelman et al., 1998, 1999), 
others have noted similar biphasic activity (Aouadi et al., 2006). Antithetical to observations 
that sustained p38 results in cell death; ectopic expression of p38 has been shown sufficient 
to promote adipocyte differentiation in 3T3-L1 preadipocytes and NIH 3T3 fibroblasts 
(Engelman et al., 1998, 1999; Aouadi et al., 2007). However, it remains uncertain if biphasic 
p38 activity or loss of activity during late differentiation is required for adipocyte 
differentiation and maintenance of the mature adipocyte phenotype.
Phosphatases are now being recognized as key modulators and even controllers of cellular 
signaling and biological processes including proliferation and differentiation. This is clearly 
evident in reports that demonstrate that DUSPs control MAPK dephosphorylation of 
myocyte, osteocyte, and neuronal cells (Bennett and Tonks, 1997; Reffas and Schlegel, 
2000; Matsuguchi et al., 2009), where timely MAPK phosphorylation and 
dephosphorylation dictates cellular growth and differentiation of these cell types (Bennett 
and Tonks, 1997; Matsuguchi et al., 2009; Datta et al., 2010). For instance, DUSP1-
mediated ERK dephosphorylation has been shown necessary for muscle-specific gene 
expression and myogenesis. Conversely, prolonged ERK phosphorylation due to loss of 
DUSP1 blocked myogenesis (Bennett and Tonks, 1997). Likewise, loss of DUSP1 markedly 
increased ERK phosphorylation during late osteoblast differentiation, in which ERK 
dephosphorylation is required for terminal growth arrest and bone formation (Datta et al., 
2010).
Recent reports have begun highlighting the potential role for DUSPs as negative regulators 
of the mature adipocyte phenotype (Xu et al., 2003b; Sakaue et al., 2004; Wu et al., 2006; 
Feng et al., 2014). Already, reports have shown that mice globally lacking DUSP1 or 
DUSP6 are protected from DIO. However, decreases in adiposity in these knockout mice 
were attributed to increases in energy expenditure and not inhibition of adipocyte 
differentiation per se (Wu et al., 2006; Feng et al., 2014). While a few reports have linked 
ectopic expression of DUSPs, in particular DUSP1 and DUSP9, to inhibition of IR in 
adipocytes (Xu et al., 2003b; Bazuine et al., 2004; Emanuelli et al., 2008), only three papers 
have examined a role for DUSPs on adipocyte differentiation (Xu et al., 2003b; Sakaue et 
al., 2004; Wu et al., 2006). In these reports, DUSP1 and DUSP9 have again been the only 
DUSPs examined as negative regulators of MAPK signaling and adipogenesis (Xu et al., 
2003b; Sakaue et al., 2004; Wu et al., 2006). Converse to our findings that DUSP1 acts as an 
immediate early gene to regulate MAPK dephosphorylation, Sakaue and Colleagues (Sakaue 
et al., 2004) reported that DUSP1 expression increased during late stages of adipocyte 
differentiation, with peak expression observed at day 6 of differentiation. In addition, they 
report that loss of DUSP1 with anti-sense RNA blocked adipocyte differentiation (Sakaue et 
al., 2004). In contrast to Sakaue et al. (2004), DUSP1 knockout mouse embryonic fibroblasts 
(MEFs) were reported to differentiate equally as well when compared to wild-type 
counterparts, suggesting that DUSP1 is not essential for adipocyte differentiation (Wu et al., 
2006). Consistent with this report, we found that genetic loss of DUSP1 did not block 
adipocyte differentiation. In fact, examination of cyclin A in our study suggested that S-
phase transition was more efficient in the presence of increased MAPK signaling. This 
observation is consistent with Schroder et al. (Schroder et al., 2009) where DUSP1 
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knockdown enhanced preadipocyte proliferation. Thus, while DUSP1 appears essential for 
MAPK dephosphorylation, its role with adipocyte differentiation remains unresolved.
In summary, our data suggest that chronic, low-grade inflammation associated with obesity 
drives DUSP1 expression in adipose tissue. Based on our findings, we would postulate that 
induction of DUSP1 gene expression acts in a compensatory manner to mitigate MAPK 
signaling and inflammation in adipose tissue. In the preadipocyte (stromal vascular fraction 
of adipose tissue), increased DUSP1 potentially acts to maintain MAPK signaling to favor 
adipocyte differentiation and prevent preadipocyte dysfunction. Indeed PKA and ERK 
signaling induced DUSP1 expression to feedback inhibit ERK and p38 phosphorylation. 
While knockdown of DUSP1 alone was not sufficient to block adipogenesis, induction other 
MAPK-specific DUSPs (Fig. 7) suggest redundancy for MAPK signaling regulation. In 
keeping, several of these ‘inducible’ DUSPs were also significantly upregulated in obese 
animals (Fig. 8), suggesting a co-operative and compensatory role for these ‘inducible’ 
phosphatases on the maintenance of adipocyte function in response to obesity and chronic, 
low-grade inflammation. Future research into the role of other early ‘inducible’ DUSPs, 
identified in this study, in the regulation of adipocyte differentiation will be of great interest. 
In addition, while some evidence suggests that ectopic expression of DUSP9 blocks 
adipocyte differentiation (Xu et al., 2003b), a role for late stage ‘inducible’ DUSPs 
regarding MAPK signaling, adipogenesis, and insulin resistance will also be of keen interest.
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Adipose tissue specific regulation of DUSP1 and inflammatory mediators during the 
development of obesity under conditions of genetic and diet-induced obesity. Total RNA was 
prepared from white adipose tissue (WAT) harvested during development of genetic obesity 
at (A) 6 and (B) 10 weeks of age from male B6-ob/ob mice and their lean litter mates. For 
development of diet-induced obesity (DIO), C57BL/6J males were given ad libitum access 
to a high fat diet (HFD; 60% kcal) starting at 6 weeks of age. Control males were fed a 
control low fat diet (LFD) containing 10% kcal from fat and the same protein content as the 
HFD. RNA was isolated from WAT at (C) 18 and (D) 24 weeks of age. Relative DUSP 
mRNA abundance was measured via qRT-PCR and statistical significance determined by 
student’s t-test (P<0.05). All data were normalized to 18S rRNA and expressed relative to 
lean littermates.
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MAPK dephosphorylation is strongly correlated with DUSP1 expression. PAs were 
stimulated with MDI and cell lysates harvested during (A) early (0–24 h) and (C) late 
differentiation (d0–d8) prior to immunoblot analysis of phosphorylated MEK, ERK, and p38 
as well as DUSP1, total p38 and PPARγ. In addition, PAs were stimulated with MDI and 
RNA isolated during (B) early (0–24h) and (D) late differentiation (d0–d8) prior to qRT-
PCR analysis of DUSP1. DUSP1 was normalized to 18S rRNA and expressed relative to 
untreated cells (0 h or 0 d). DUSP1 was considered inducible when upregulated above a 
twofold criterion.
FERGUSON et al. Page 20














Inhibition of DUSP1 enhances ERK and p38 phosphorylation during early adipocyte 
differentiation. (A) PAs were pretreated (30 min) in the absence or presence of 1 ng/ml 
Actinomycin D (AD) prior to MDI stimulation. Cell lysates were collected over time and 
protein expression of phosphorylated ERK and p38 along with DUSP1 and GAPDH 
analyzed via immunoblotting. (B) In addition, PAs were pretreated (30 min) in the presence 
or absence of 1 μM triptolide (TRP) prior to MDI stimulation. Cell lysates were collected 
over time post-MDI and protein expression of phosphorylated ERK and p38 along with 
DUSP1 and α-Tubulin examined via immunoblotting.
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DUSP1 knockdown enhances ERK and p38 signaling magnitude and duration during early 
adipocyte differentiation. PAs were transfected with non-targeting control siRNA or DUSP1-
specific siRNA for 72 h prior to stimulation with MDI. (A) Cell lysates were harvested for 
RNA at 0 and 1 h post-MDI and mRNA expression of DUSP1 analyzed via qRT-PCR. Data 
were normalized to 18S rRNA and changes in gene expression measured as fold differences 
relative to untreated control siRNA (0h). Statistical differences were determined by ANOVA, 
with Tukey’s post-hoc analysis performed when the p value for the respective parameter was 
statistically significant (P<0.05). (B) Cell lysates were collected over time post-MDI for 
control siRNA and DUSP1 siRNA and protein expression of phosphorylated ERK and p38 
along with DUSP1, total p38, and α-Tubulin examined via immunoblotting.
FERGUSON et al. Page 22














Regulation of DUSP1 by PKA and ERK signaling. PAs were stimulated in the absence or 
presence of the adipogenic cocktail for 1 h either individually or in combination prior to 
qRT-PCR analysis of (A) DUSP1 or (B) C/EBPβ. In addition, PAs were pretreated with the 
PKA inhibitor H-89 (30 min) or MEK inhibitor UO126 (30 min) prior to (C) qRT-PCR 
analysis of DUSP1 or (D) immunoblot analysis of phosphorylated ERK, p38, DUSP1 and C/
EBPβ. All RT-PCR data were normalized to 18S rRNA and changes in gene expression 
measured as fold differences relative to untreated cells (0 h). For panels A&B, statistical 
differences between treated and control (d0) were determined by ANOVA with Dunnet’s 
post-hoc analysis performed when the P value for the respective parameter was statistically 
significant (P<0.05). For panel C, statistical differences treated and control (d0) were 
determined by ANOVA with Tukey’s post-hoc analysis performed when the P value for the 
respective parameter was statistically significant (P<0.05).
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DUSP1 knockdown does not inhibit 3T3-L1 adipogenesis. PAs were transfected with non-
targeting control siRNA or dusp1-specific siRNA for 72 hrs prior to stimulation with MDI. 
(A) Cells were fixed at d0 and 20 h post-MDI and DNA stained with propidium iodide. 
DNA histograms were assessed via flow cytometry. (B) Cell lysates were collected over time 
and protein expression of DUSP1, cyclin A, and α-Tubulin examined via immunoblotting. 
(C) Examination of cell morphology of untreated preadipocytes and mature adipocytes 
treated with control siRNA or dusp1 siRNA was assessed for lipid accumulation using phase 
contrast microscopy at 10× and 20× magnitudes. (D) Cell lysates were collected from PAs 
(d0) and mature ADs (d8) treated with control siRNA (C) or DUSP1 siRNA (D1) and 
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protein expression of adipocyte genes PPARγ, C/EBPα, and aP2 examined via immunoblot 
analysis.
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Mitogen-mediated induction of DUSPs during adipocyte differentiation. PAs (d0) were 
stimulated with MDI for adipocyte differentiation. Total RNA was harvested from PAs (d0) 
stimulated with MDI to examine (A) early inducible or (B) non-inducible DUSPs and (C) 
late inducible and (D) non-inducible DUSPs during differentiation. DUSP mRNA was 
assessed by qRT-PCR. All data were normalized to 18S rRNA and expressed relative to 
untreated cells (0 h). Genes selected as inducible were upregulated above a twofold criterion 
indicated by a dashed line on the graph.
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Adipose tissue specific regulation of DUSPs under conditions of diet-induced obesity. Total 
RNA was prepared from white adipose tissue (WAT) harvested at 18 weeks of age from diet-
induced obesity (DIO), C57BL/6J males given ad libitum access to a high fat diet (HFD; 
60% kcal) starting at 6 weeks of age. Control males were fed a control low fat diet (LFD) 
containing 10% kcal from fat and the same protein content as the HFD. Relative DUSP 
mRNA abundance was measured via qRT-PCR and statistical significance determined by 
student’s t-test (P<0.05). All data were normalized to 18S rRNA and expressed relative to 
lean littermates.
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Model for the regulation of MAPK signaling and adipocyte differentiation by DUSPs. 
Adipogenic stimuli (MDI) increase PKA/MAPK-dependent dusp1 expression leading to 
dephosphorylation and inhibition of ERK and p38 activity. MDI-dependent stimulation of 
additional MAPK-specific DUSPs also inhibit MAPK activation (dotted line). Together, 
DUSP-mediated regulation of MAPK signaling can alter adipogenic gene expression and 
adipocyte differentiation.
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TABLE 2.
Anthropometrics of mice in this study
Stage Age (week) Final BW (g) % Δ
Genetic obesity lean ob/obb
 I 6 21.8 36.4 67
 II 10 28.6 52.4 83
Diet-induced obesity LFD HFD
 I 18 30.8 34.7 13
 II 24 32.2 40.6 26
Percent difference in body weight (BW) between lean and obese mice (%Δ).
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